Summary Rationale Effective treatment for drug susceptible tuberculosis rapidly renders patients non-infectious – long before sputum acid-fast smear or culture conversion to negative. Multidrug-resistant tuberculosis (MDR-TB) patients on treatment are currently assumed to remain infectious for months. While the resources required for prolonged hospitalization are a barrier to MDR-TB treatment scale-up, the safety of community treatment is clear. Objectives To estimate the impact of effect treatment on MDR-TB patient infectiousness. Methods A series of five human-to-guinea pig tuberculosis transmission studies tested various infection control interventions. Exhaust air from a hospital ward occupied by mostly sputum smear and culture positive MDR-TB patients exposed guinea pigs in adjacent chambers. Guinea pigs were tuberculin skin tested for infection. Only the control groups of guinea pigs from each study (no interventions used) provide the data for this analysis. Measurements The number of guinea pigs infected in each study is reported and correlated with M. tuberculosis drug susceptibility relative to treatment. Main Results Despite exposure to presumably infectious MDR-TB patients, guinea pig infection percentages ranged from 1 to 77% among the 5 experiments. In one experiment, in which 27 MDR-TB patients newly started on effective treatment exposed guinea pigs for 3 months, there was minimal transmission. In 4 other experiments with greater transmission, guinea pigs had been exposed to patients with unsuspected extensively drug resistant tuberculosis (XDR-TB) - not on effective treatment. Conclusions In this model, effective treatment appears to render MDR-TB patients rapidly non-infectious. Further prospective studies on this subject are needed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.